Allergan expected to post EPS of $4.73 for 2017 — 3 insights

Written by Eric Oliver | January 31, 2018 | Print  |

Stock market analysts anticipate Allergan will report full-year earnings of $4.73 per share Feb. 14, according to the Frisco Fastball.


Here's what you should know:

1. Analysts believe Allergan will announce fourth quarter 2017 earnings of $0.83 per share Feb. 14, as well.

2. Analysts believe the company's full-year earnings will increase approximately 13.98 percent, year over year.

3. Based on the projected earnings, 18 analysts awarded Allergan a "buy" rating and eight have deemed it a "hold." No analysts issued a "sell" rating.

More articles on supply chain:
Healthcare-related lobbying hits $555M in 2017 — 6 statistics on lobbying in healthcare
Advanced Medical Group joins National Spine & Pain Centers — 4 things to know
Preoperative opioid users more likely to abuse opioids after TKA — 3 study insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.